{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:41:05Z","timestamp":1759405265232,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Ltd","doi-asserted-by":"publisher","award":["MISP 60203"],"award-info":[{"award-number":["MISP 60203"]}],"id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.vaccine.2022.09.062","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T23:54:08Z","timestamp":1664582048000},"page":"6412-6421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pathogenesis of Streptococcus pneumoniae serotype 3 during natural colonization and infections among children and its IgG correlate of protection in a mouse model"],"prefix":"10.1016","volume":"40","author":[{"given":"Naoko","family":"Fuji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pichichero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.09.062_b0005","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Causes of Death C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Mortality","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.09.062_b0010","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2022.09.062_b0015","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial","volume":"196","author":"O'Brien","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.062_b0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.062_b0025","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2217\/fmb.15.81","article-title":"Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children","volume":"10","author":"Esposito S, Principi N, Group EVS","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.09.062_b0035","doi-asserted-by":"crossref","first-page":"591580","DOI":"10.1155\/2015\/591580","article-title":"Impacts of the 13-valent pneumococcal conjugate vaccine in children","volume":"2015","author":"Esposito","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2022.09.062_b0040","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","article-title":"Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction","volume":"33","author":"Gladstone","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.062_b0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.062_b0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S2352-4642(18)30168-8","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study","volume":"2","author":"Pichichero","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.vaccine.2022.09.062_b0055","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.vaccine.2019.10.056","article-title":"Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion\/empyema after the introduction of PCV13 in Germany","volume":"38","author":"Goettler","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.062_b0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.062_b0065","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.062_b0070","doi-asserted-by":"crossref","first-page":"e00198","DOI":"10.1016\/j.heliyon.2016.e00198","article-title":"The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination","volume":"2","author":"Slotved","year":"2016","journal-title":"Heliyon"},{"key":"10.1016\/j.vaccine.2022.09.062_b0075","doi-asserted-by":"crossref","first-page":"e0226353","DOI":"10.1371\/journal.pone.0226353","article-title":"The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007\u20132017","volume":"14","author":"Wijayasri","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.09.062_b0080","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.062_b0085","doi-asserted-by":"crossref","first-page":"613287","DOI":"10.3389\/fcimb.2020.613287","article-title":"Sugar-coated killer: serotype 3 pneumococcal disease","volume":"10","author":"Luck","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0090","unstructured":"Zhang ZWaJ-R. Chapter 3 \u2013 bacterial capsules, molecular medical microbiology. 2nd ed.; 2015."},{"key":"10.1016\/j.vaccine.2022.09.062_b0095","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1074\/jbc.M511124200","article-title":"Role of the carbohydrate binding site of the Streptococcus pneumoniae capsular polysaccharide type 3 synthase in the transition from oligosaccharide to polysaccharide synthesis","volume":"281","author":"Forsee","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2022.09.062_b0100","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1073\/pnas.1620431114","article-title":"Streptococcus pneumoniae capsular polysaccharide is linked to peptidoglycan via a direct glycosidic bond to beta-D-N-acetylglucosamine","volume":"114","author":"Larson","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2022.09.062_b0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/CVI.00591-15","article-title":"Capsular Polysaccharide (CPS) release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 CPS antibodies","volume":"23","author":"Choi","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0110","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1128\/JB.187.13.4470-4479.2005","article-title":"Initiation and synthesis of the Streptococcus pneumoniae type 3 capsule on a phosphatidylglycerol membrane anchor","volume":"187","author":"Cartee","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jcp.2006.041210","article-title":"Anti-pneumococcal antibody titre measurement: what useful information does it yield?","volume":"60","author":"Balmer","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0120","unstructured":"World Health Organization. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series; 2005. p. 64\u201398."},{"key":"10.1016\/j.vaccine.2022.09.062_b0125","unstructured":"World Health Organization. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series,; 2013. p. 91-151."},{"key":"10.1016\/j.vaccine.2022.09.062_b0130","doi-asserted-by":"crossref","unstructured":"Abghari PF, Poowuttikul P, Secord E. Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin. Glob Pediatr Health. 2017;4:2333794X16689639.","DOI":"10.1177\/2333794X16689639"},{"key":"10.1016\/j.vaccine.2022.09.062_b0135","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1080\/21645515.2015.1033600","article-title":"Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines","volume":"11","author":"Principi","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.09.062_b0140","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.vaccine.2021.05.089","article-title":"Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A that correlate with protection from colonization and acute otitis media in children","volume":"39","author":"Kaur","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.062_b0145","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/INF.0b013e31828d9acc","article-title":"Acute otitis media otopathogens during 2008 to 2010 in Rochester","volume":"32","author":"Casey","year":"2013","journal-title":"New York Pediatr Infect Dis J"},{"year":"2003","series-title":"Manual of clinical microbiology","author":"Patrick","key":"10.1016\/j.vaccine.2022.09.062_b0150"},{"key":"10.1016\/j.vaccine.2022.09.062_b0155","doi-asserted-by":"crossref","first-page":"e19844","DOI":"10.1371\/journal.pone.0019844","article-title":"Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease","volume":"6","author":"Trappetti","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.09.062_b0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-1-61779-373-8_24","article-title":"Measurement of antibodies to pneumococcal polysaccharides with Luminex xMAP microsphere-based liquid arrays","volume":"808","author":"Pickering","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0165","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2020.04.063","article-title":"Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine","volume":"38","author":"Kaur","year":"2020","journal-title":"Vaccine"},{"year":"2003","series-title":"Handbook of laboratory animal management and welfare","author":"Sarah Wolfensohn","key":"10.1016\/j.vaccine.2022.09.062_b0170"},{"key":"10.1016\/j.vaccine.2022.09.062_b0175","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1128\/IAI.73.8.4653-4667.2005","article-title":"Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells","volume":"73","author":"Hammerschmidt","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.09.062_b0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","article-title":"Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease","volume":"29","author":"Yildirim","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.062_b0185","doi-asserted-by":"crossref","unstructured":"Park IH, Kim KH, Andrade AL, Briles DE, McDaniel LS, Nahm MH. Nontypeable pneumococci can be divided into multiple cps types, including one type expressing the novel gene pspK. mBio. 2012;3.","DOI":"10.1128\/mBio.00035-12"},{"key":"10.1016\/j.vaccine.2022.09.062_b0190","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3389\/fimmu.2018.01366","article-title":"Streptococcus pneumoniae's virulence and host immunity: aging, diagnostics, and prevention","volume":"9","author":"Brooks","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0195","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/IAI.00881-09","article-title":"The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms","volume":"78","author":"Hyams","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.09.062_b0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/MMBR.65.2.187-207.2001","article-title":"Pneumococcal virulence factors: structure and function","volume":"65","author":"Jedrzejas","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2022.09.062_b0205","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrmicro1871","article-title":"The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease","volume":"6","author":"Kadioglu","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0210","first-page":"215","article-title":"Inflammasomes in pneumococcal infection: innate immune sensing and bacterial evasion strategies","volume":"397","author":"Rabes","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0215","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1462-5822.2006.00857.x","article-title":"Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps","volume":"9","author":"Wartha","year":"2007","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2022.09.062_b0220","doi-asserted-by":"crossref","first-page":"e1003862","DOI":"10.1371\/journal.ppat.1003862","article-title":"Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose","volume":"10","author":"Krismer","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2022.09.062_b0225","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00802-17","article-title":"Capsule Prolongs Survival of Streptococcus pneumoniae during Starvation","volume":"86","author":"Hamaguchi","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.09.062_b0230","first-page":"9990","article-title":"High-resolution analysis of the pneumococcal transcriptome under a wide range of infection-relevant conditions","volume":"46","author":"Aprianto","year":"2018","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2022.09.062_b0235","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/iai.62.6.2582-2589.1994","article-title":"Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization","volume":"62","author":"Weiser","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.09.062_b0240","doi-asserted-by":"crossref","first-page":"e0177113","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.09.062_b0245","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/21645515.2015.1118593","article-title":"Interim results of an ecological experiment - conjugate vaccination against the pneumococcus and serotype replacement","volume":"12","author":"Hausdorff","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.09.062_b0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-12-207","article-title":"Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective","volume":"12","author":"Weil-Olivier","year":"2012","journal-title":"BMC Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:19:29Z","timestamp":1759403969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22011823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":50,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0264410X22011823"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of Streptococcus pneumoniae serotype 3 during natural colonization and infections among children and its IgG correlate of protection in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}